Laboratorios Farmaceuticos Rovi Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of LABF.F?
Owner Type	Number of Shares	Ownership Percentage
General Public	7,543,595	14.7%
Institutions	11,062,485	21.6%
Private Companies	32,543,418	63.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 80.54% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
58.3%	Norbel Inversiones S.L.	29,811,821	US$1.9b	0%	no data
5.34%	Global Portfolio Investments, S. L.	2,731,597	US$175.7m	0%	no data
2.27%	Capital Research and Management Company	1,160,933	US$74.7m	-11.6%	no data
1.54%	The Vanguard Group, Inc.	787,402	US$50.6m	-0.02%	no data
1.42%	T. Rowe Price Group, Inc.	728,709	US$46.9m	-15.6%	no data
1.34%	Santander Asset Management SA SGIIC	685,590	US$44.1m	0%	0.22%
1.02%	Invesco Ltd.	524,151	US$33.7m	-2.37%	0.01%
0.98%	Norges Bank Investment Management	502,015	US$32.3m	0%	no data
0.87%	RBC Global Asset Management Inc.	444,956	US$28.6m	0%	0.02%
0.82%	EDM Gestion, S.G.I.I.C., S.A.	417,636	US$26.9m	0%	2.49%
0.8%	Dimensional Fund Advisors LP	411,713	US$26.5m	-0.01%	no data
0.73%	BNP Paribas Asset Management Europe	375,436	US$24.1m	0%	0.06%
0.63%	BlackRock, Inc.	319,881	US$20.6m	1.32%	no data
0.57%	BNPP Asset Management Holding	290,626	US$18.7m	0%	0.03%
0.54%	Wellington Management Group LLP	275,954	US$17.7m	0%	no data
0.53%	M&G Investment Management Limited	272,801	US$17.5m	0%	0.04%
0.51%	BN & Partners Capital AG, Asset Management Arm	262,873	US$16.9m	0%	4.02%
0.46%	Tocqueville Finance SA	232,836	US$15.0m	0%	0.57%
0.4%	Muza Gestion De Activos Sgiic SA	205,384	US$13.2m	0%	5.89%
0.33%	KBC Asset Management NV	168,325	US$10.8m	0%	0.02%
0.26%	Pictet Asset Management Limited	132,791	US$8.5m	0%	0.01%
0.24%	Gesiuris, SA	120,902	US$7.8m	0%	2.75%
0.23%	Natixis Investment Managers International	117,004	US$7.5m	0%	0.03%
0.21%	Degroof Petercam Asset Management	109,272	US$7.0m	0%	0.03%
0.21%	Renta 4 Gestora S.G.I.I.C., SA	107,630	US$6.9m	0%	0.52%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/19 16:11
End of Day Share Price	2024/11/25 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Laboratorios Farmaceuticos Rovi, S.A. is covered by 18 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Álvaro Arístegui Echevarría	Ahorro Corporación
Guilherme Sampaio	Banco BPI, S.A.
Javier Esteban Lario	Banco de Sabadell. S.A.